Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXemestane in Progesterone and/or Estrogen Receptor Positive Epithelial Ovarian Cancer: A Randomized Phase III Trial, EXPERT

NCT04460807 is registered in ClinicalTrials.gov with Ente Ospedaliero Ospedali Galliera as lead sponsor.

NCT NCT04460807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04460807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXemestane in Progesterone and/or Estrogen Receptor Positive Epithelial Ovarian Cancer: A Randomized Phase III Trial, EXPERT
Lead sponsor
Ente Ospedaliero Ospedali Galliera
Phase
Phase 3
Overall status
Terminated
Start date
February 13, 2020
Completion date
April 27, 2023
Enrollment
23 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer